Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.8 EUR | +1.17% | +4.01% | +5.38% |
Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
Evolution of the average Target Price on Merck KGaA
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Merck KGaA
BARCLAYS | Emily Field |
alphavalue | Martin Schnee |
UBS | |
JEFFERIES | Brian Balchin |
DZ BANK | Peter Spengler |
JPMORGAN | Richard Vosser |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
Jefferies & Co. | |
Stifel Nicolaus | |
CREDIT SUISSE | Dominic Lunn |
GOLDMAN SACHS | Keyur Parekh |
MORGAN STANLEY | James Quigley |
BERENBERG | Diana Na |
BERNSTEIN RESEARCH | Wimal Kapadia |
DEUTSCHE BANK | Falko Friedrichs |
KEPLER CHEUVREUX | David Evans |
NORDLB | Thorsten Strauß |
WARBURG RESEARCH | Ulrich Huwald |
INDEPENDENT RESEARCH | Tobias Gottschalt |
HSBC | Stephen McGarry |
BANK OF AMERICA (BOFA) | Sachin Jain |
SOCIETE GENERALE (SOCGEN) | Florent Cespedes |
EPS Revisions
- Stock Market
- Equities
- MRK Stock
- Consensus Merck KGaA